结论SYT SSX融合基因表达可作为诊断滑膜肉瘤新的分子诊断指标。
Conclusions SYT-SSX is a reliable index for the molecular pathological diagnosis of synovial sarcoma.
FHIT基因的改变在肝细胞癌中是早期频发的事件，可以成为肝癌患者预后一种新的分子指标。
The alternation of FHIT gene is an early and frequent event of liver cancer, and FHIT gene as a new molecular indicator of liver cancer can monitor the prognosis of liver cancer patients.
结论端粒酶活化与肿瘤的恶性转化密切相关，可作为恶性血液病恶性克隆增殖的分子标志，有希望成为监测微量残留白血病的一个新指标。
Conclusions Telomerase activity could be a useful marker for evaluating malignant clonal proliferation, and it is hopeful to become a new molecular target for monitoring minimal residual leukemia.
应用推荐